207 related articles for article (PubMed ID: 35143773)
1. Copeptin in fluid disorders and stress.
Mu D; Ma C; Cheng J; Zou Y; Qiu L; Cheng X
Clin Chim Acta; 2022 Apr; 529():46-60. PubMed ID: 35143773
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin and Copeptin in health and disease.
Christ-Crain M
Rev Endocr Metab Disord; 2019 Sep; 20(3):283-294. PubMed ID: 31656992
[TBL] [Abstract][Full Text] [Related]
3. Approach to the Patient: "Utility of the Copeptin Assay".
Christ-Crain M; Refardt J; Winzeler B
J Clin Endocrinol Metab; 2022 May; 107(6):1727-1738. PubMed ID: 35137148
[TBL] [Abstract][Full Text] [Related]
4. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.
Christ-Crain M; Fenske W
Nat Rev Endocrinol; 2016 Mar; 12(3):168-76. PubMed ID: 26794439
[TBL] [Abstract][Full Text] [Related]
5. Copeptin: clinical use of a new biomarker.
Morgenthaler NG; Struck J; Jochberger S; Dünser MW
Trends Endocrinol Metab; 2008 Mar; 19(2):43-9. PubMed ID: 18291667
[TBL] [Abstract][Full Text] [Related]
6. Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.
Mu D; Cheng J; Qiu L; Cheng X
Front Cardiovasc Med; 2022; 9():901990. PubMed ID: 35859595
[TBL] [Abstract][Full Text] [Related]
7. Copeptin and its potential role in diagnosis and prognosis of various diseases.
Dobsa L; Edozien KC
Biochem Med (Zagreb); 2013; 23(2):172-90. PubMed ID: 23894863
[TBL] [Abstract][Full Text] [Related]
8. Potential Clinical Utility of Copeptin (C-terminal provasopressin) measurements in clinical medicine.
Lewandowski KC; Brabant G
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):173-7. PubMed ID: 27008633
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
[TBL] [Abstract][Full Text] [Related]
10. Copeptin: Up-to-date diagnostic and prognostic role highlight.
Abdelmageed M; Güzelgül F
Anal Biochem; 2023 Jul; 673():115181. PubMed ID: 37247750
[TBL] [Abstract][Full Text] [Related]
11. Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers.
Fenske WK; Schnyder I; Koch G; Walti C; Pfister M; Kopp P; Fassnacht M; Strauss K; Christ-Crain M
J Clin Endocrinol Metab; 2018 Feb; 103(2):505-513. PubMed ID: 29267966
[TBL] [Abstract][Full Text] [Related]
12. Review novel insights into the diagnostic and prognostic function of copeptin in daily clinical practice.
Wu P; Wang L; Su X; Wang B; Cheng Y
Mol Biol Rep; 2023 Apr; 50(4):3755-3765. PubMed ID: 36662451
[TBL] [Abstract][Full Text] [Related]
13. Arginine Vasopressin and Copeptin in Perinatology.
Evers KS; Wellmann S
Front Pediatr; 2016; 4():75. PubMed ID: 27532032
[TBL] [Abstract][Full Text] [Related]
14. The stress hormone copeptin: a new prognostic biomarker in acute illness.
Katan M; Christ-Crain M
Swiss Med Wkly; 2010; 140():w13101. PubMed ID: 20872295
[TBL] [Abstract][Full Text] [Related]
15. Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis.
Refardt J; Winzeler B; Christ-Crain M
Clin Endocrinol (Oxf); 2019 Jul; 91(1):22-32. PubMed ID: 31004513
[TBL] [Abstract][Full Text] [Related]
16. Copeptin: Pathophysiology and potential clinical impact.
Łukaszyk E; Małyszko J
Adv Med Sci; 2015 Sep; 60(2):335-41. PubMed ID: 26233637
[TBL] [Abstract][Full Text] [Related]
17. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.
Vergier J; Fromonot J; Alvares De Azevedo Macedo A; Godefroy A; Marquant E; Guieu R; Tsimaratos M; Reynaud R
Arch Pediatr; 2018 Jan; 25(1):45-47. PubMed ID: 29241593
[TBL] [Abstract][Full Text] [Related]
18. Copeptin as a novel biomarker of cardiometabolic syndrome.
Szmygin H; Szydełko J; Matyjaszek-Matuszek B
Endokrynol Pol; 2021; 72(5):566-571. PubMed ID: 34378786
[TBL] [Abstract][Full Text] [Related]
19. Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia.
Christ-Crain M; Morgenthaler NG; Fenske W
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):235-47. PubMed ID: 27156761
[TBL] [Abstract][Full Text] [Related]
20. The role of copeptin in kidney disease.
Iglesias P; Silvestre RA; Fernández-Reyes MJ; Díez JJ
Endocrine; 2023 Mar; 79(3):420-429. PubMed ID: 36242751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
